Redmile Biopharma Investments III, L.P.'s Net Worth

Estimate Recalculated Jun 18, 2025 08:33PM EST

Who is Redmile Biopharma Investments III, L.P.

Redmile Biopharma Investments III, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adagio Therapeutics, Inc., and Entrada Therapeutics, Inc..

SEC CIK

Redmile Biopharma Investments III, L.P.'s CIK is 0001838746

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adagio Therapeutics, Inc.

Investor

Updated Aug 05, 2021

View Quote Details


Form 3	—	—	—	—	Aug 05, 2021	—	—	—	—

Showing 1 results

Entrada Therapeutics, Inc.

Investor

Updated Nov 04, 2021

View Quote Details


Form 4	104.78%	1.00M	$20.00	—	Nov 04, 2021	1.95M	Purchase	—	Nov 02
Form 3	—	—	—	—	Oct 28, 2021	—	—	—	—

Showing 2 results